Clinical Trial Update: A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 study assessing subcutaneous Mircera for anemia in chronic kidney disease patients not treated with ESAs or on dialysis; the trial has completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-04-06